Capacity tightness persists as demand forecasts point to double-digit growth through 2032
Microencapsulation Market 2025 to 2032: Tightening Capacity, Regulatory Convergence and the Growth of Precision Delivery →Analyses (Aug 17, 2026) project the market growing at a 10.68%–12.9% CAGR from a ~$15.6–17.3B base to $36–39B by 2032–2034, driven largely by pharma (32–40% of revenue). Capital-intensive encapsulation infrastructure keeps expansion slow for smaller formulators, while spray drying holds ~40% of technology share. Regulatory convergence toward bio-based, microplastic-free shell materials is also reshaping qualified supplier lists.
Lock in multi-year capacity agreements with spray-drying suppliers ahead of forecast demand growth
Projected double-digit growth against capital-constrained supply suggests tightening lead times over the planning horizon.
Audit shell-material suppliers for microplastic-free, bio-based wall material readiness
Regulatory convergence toward natural proteins, plant gums, and carbohydrates may disqualify synthetic-polymer-dependent suppliers.